JBCHEPHARM (J.B. Chemicals & Pharmaceuticals Ltd.): Acquisition / M&A
J.B. Chemicals & Pharmaceuticals Ltd. has announced that trading in its equity shares will be suspended from the closing hours of July 16, 2026, due to a Scheme of Amalgamation, according to an NSE filing dated July 13. The company had earlier informed the exchange that the record date for the merger is July 17, 2026. The stock closed at ₹2,460 on July 10, up 1.01% from its previous close of ₹2,435.5.
Events like this—acquisitions and mergers in the Indian market—have historically shown a 48.9% win rate across 141 comparable instances, with a net edge of 0.213%, according to Strota's base rate data. This represents the historical frequency of positive outcomes following such corporate events, not a forecast for this specific transaction.
The stock has gained 2.99% over the past week, 8.11% over one month, and 21.87% over three months, now trading just 1.56% below its 52-week high of ₹2,474. Relative volume stands at 1.3 times average. The RSI-14 reading of 78.9 indicates technically overbought conditions. Valuation metrics show a price-to-earnings ratio of 55.19 and price-to-book of 9.5, with return on equity at 18.7%.
The data establishes that the merger suspension is proceeding on schedule and that the stock has outperformed significantly over the past year with a 49.15% return. It does not establish the final exchange ratio, the post-merger listing timeline, or whether current valuations will be sustained in the combined entity.
The catalyst
Members of the Exchange are hereby informed that the trading in equity shares of JB Chemicals & Pharmaceuticals Limited shall be suspended w.e.f. July 17, 2026 (i.e., closing hours of trading on July 16, 2026) on account of the Scheme of Amalgamation. · NSE
What the data shows after this event
Across Strota's backtest of past filings, Acquisition / M&A shows no reliable next-session edge — the move went bullish in about 48.9% of next sessions (net 0.213% after drift and cost, n=141). A base rate, not a forecast for this stock.
JBCHEPHARM right now
trading +1.01% on the day; P/E 55.19; RSI 78.9. Full JBCHEPHARM analysis →
Sources
- J B Chemicals & Pharmaceuticals Ltd up for fifth session — Business Standard
- JB Chemicals gets NCLT nod for merger with Torrent Pharma; everything investors need to know — Upstox
- NCLT clears Torrent Pharma's merger with JB Chemicals — CNBC TV18
- J B Chemicals & Pharmaceuticals Ltd gains for third consecutive session — Business Standard
Keep digging
- JBCHEPHARM — full smart-money page: F&O positioning, deals, insider filings and option chain in one place.
- Today's screens: every stock matching the same setups (buildups, breakouts, volume shockers).
- Newsroom: the other stocks in play this session.